Thyroid Gland Disorder Treatment Market Size, Share, Trends, Growth 2032
Thyroid Gland Disorder Treatment Market By Disease Type (Hypothyroidism, Hyperthyroidism), By Drug Type (Liothyronine, Levothyroxine, Imidazole, Propacil, Others), And By Region - Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2024 - 2032
| Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 2.42 Billion | USD 3.17 Billion | 3.18% | 2023 |
Table Of Content
- Chapter 1 Preface
- 1.1 Report Description
- 1.1 Report Scope
- Chapter 2 Research Methodology
- 2.1 Research Methodology
- 2.2 Secondary Research
- 2.3 Primary Research
- 2.4 Models
- 2.4.1 Company Share Analysis Model
- 2.4.2 Revenue Based Modelling
- 2.5 Research Limitations
- Chapter 3 Executive Summary
- 3.1 Global Thyroid Gland Disorder Treatment Market, 2016 – 2026 (USD Million)
- 3.2 Global Thyroid Gland Disorder Treatment Market: Snapshot
- Chapter 4 Thyroid Gland Disorder Treatment Market – Industry Analysis
- 4.1 Introduction
- 4.2 Market Drivers
- 4.2.1 Driving Factor 1 Analysis
- 4.2.2 Driving Factor 2 Analysis:
- 4.3 Market Restraints
- 4.3.1 Restraining Factor Analysis
- 4.4 Market Opportunities
- 4.4.1 Market Opportunity & Use-case Analysis
- 4.4.2 Use – Cases for Thyroid Gland Disorder Treatment
- 4.5 Porter’s Five Forces Analysis
- 4.6 COVID 19 Impact Analysis
- 4.6.1.1 Impact on Product Development and Technology Adoption
- 4.6.1.2 Gap Analysis
- Chapter 5 Investment Proposition Analysis
- 5.1 Global Thyroid Gland Disorder Treatment Market Attractiveness, By Disease Type
- 5.2 Global Thyroid Gland Disorder Treatment Market Attractiveness, By Drug Type
- 5.3 Global Thyroid Gland Disorder Treatment Market Attractiveness, By Region
- Chapter 6 Competitive Landscape
- 6.1 Company Market Share Analysis - 2019
- 6.1.1 Global Thyroid Gland Disorder Treatment Market: Company Market Share, 2019
- 6.2 Strategic Developments
- 7.1 Global Thyroid Gland Disorder Treatment Market Overview: By Disease Type
- 7.1.1 Global Thyroid Gland Disorder Treatment Market Revenue Share, By Disease Type, 2019 & 2026
- 7.2 Global Thyroid Gland Disorder Treatment Market Analysis/Overview –By Disease Type
- 7.2.1 Hypothyroidism – Overview/Analysis
- 7.2.2 Hyperthyroidism – Overview/Analysis
- 7.3 Hypothyroidism
- 7.3.1 Global Thyroid Gland Disorder Treatment Market for Hypothyroidism, Revenue (USD Million) 2016 - 2026
- 7.4 Hyperthyroidism
- 7.4.1 Global Thyroid Gland Disorder Treatment Market for Hyperthyroidism, Revenue (USD Million) 2016 - 2026
- 8.1 Global Thyroid Gland Disorder Treatment Market Overview: By Drug Type
- 8.1.1 Global Thyroid Gland Disorder Treatment Market Revenue Share, By Drug Type, 2019 & 2026
- 8.2 Global Thyroid Gland Disorder Treatment Market Analysis/Overview –By Drug Type
- 8.2.1 Liothyronine – Overview/Analysis
- 8.2.2 Levothyroxine – Overview/Analysis
- 8.2.3 Imidazule – Overview/Analysis
- 8.2.4 Propacil – Overview/Analysis
- 8.2.5 Others – Overview/Analysis
- 8.3 Liothyronine
- 8.3.1 Global Thyroid Gland Disorder Treatment Market for Liothyronine, Revenue (USD Million) 2016 - 2026
- 8.4 Levothyroxine
- 8.4.1 Global Thyroid Gland Disorder Treatment Market for Levothyroxine, Revenue (USD Million) 2016 - 2026
- 8.5 Imidazule
- 8.5.1 Global Thyroid Gland Disorder Treatment Market for Imidazule, Revenue (USD Million) 2016 - 2026
- 8.6 Propacil
- 8.6.1 Global Thyroid Gland Disorder Treatment Market for Propacil, Revenue (USD Million) 2016 - 2026
- 8.7 Others
- 8.7.1 Global Thyroid Gland Disorder Treatment Market for Others, Revenue (USD Million) 2016 - 2026
- 6.1 Company Market Share Analysis - 2019
- Chapter 9 Thyroid Gland Disorder Treatment Market – Regional Analysis
- 9.1 Global Thyroid Gland Disorder Treatment Market: Regional Overview
- 9.1.1 Global Thyroid Gland Disorder Treatment Market Revenue Share, by Region, 2019 & 2026
- 9.1.2 Global Thyroid Gland Disorder Treatment Market Revenue, by Region, 2016 – 2026 (USD Million)
- 9.2 North America
- 9.2.1 North America Thyroid Gland Disorder Treatment Market Revenue, 2016 - 2026 (USD Million)
- 9.2.2 North America Thyroid Gland Disorder Treatment Market Revenue, by Country, 2016 – 2026 (USD Million)
- 9.2.3 North America Thyroid Gland Disorder Treatment Market Revenue, By Disease Type, 2016 – 2026
- 9.2.4 North America Thyroid Gland Disorder Treatment Market Revenue, By Drug Type, 2016 – 2026
- 9.2.5 U.S.
- 9.2.6 Canada
- 9.3 Europe
- 9.3.1 Europe Thyroid Gland Disorder Treatment Market Revenue, 2016 - 2026 (USD Million)
- 9.3.2 Europe Thyroid Gland Disorder Treatment Market Revenue, by Country, 2016 – 2026 (USD Million)
- 9.3.3 Europe Thyroid Gland Disorder Treatment Market Revenue, By Disease Type, 2016 – 2026
- 9.3.4 Europe Thyroid Gland Disorder Treatment Market Revenue, By Drug Type, 2016 – 2026
- 9.3.5 Germany
- 9.3.6 France
- 9.3.7 U.K.
- 9.3.8 Rest of Europe
- 9.4 Asia Pacific
- 9.4.1 Asia Pacific Thyroid Gland Disorder Treatment Market Revenue, 2016 - 2026 (USD Million)
- 9.4.2 Asia Pacific Thyroid Gland Disorder Treatment Market Revenue, by Country, 2016 – 2026 (USD Million)
- 9.4.3 Asia Pacific Thyroid Gland Disorder Treatment Market Revenue, By Disease Type, 2016 – 2026
- 9.4.4 Asia Pacific Thyroid Gland Disorder Treatment Market Revenue, By Drug Type, 2016 – 2026
- 9.4.5 China
- 9.4.6 Japan
- 9.4.7 India
- 9.4.8 Rest of Asia Pacific
- 9.5 Latin America
- 9.5.1 Latin America Thyroid Gland Disorder Treatment Market Revenue, 2016 - 2026 (USD Million)
- 9.5.2 Latin America Thyroid Gland Disorder Treatment Market Revenue, by Country, 2016 – 2026 (USD Million)
- 9.5.3 Latin America Thyroid Gland Disorder Treatment Market Revenue, By Disease Type, 2016 – 2026
- 9.5.4 Latin America Thyroid Gland Disorder Treatment Market Revenue, By Drug Type, 2016 – 2026
- 9.5.5 Brazil
- 9.5.6 Rest of Latin America
- 9.6 The Middle-East and Africa
- 9.6.1 The Middle-East and Africa Thyroid Gland Disorder Treatment Market Revenue, 2016 - 2026 (USD Million)
- 9.6.2 The Middle-East and Africa Thyroid Gland Disorder Treatment Market Revenue, by Country, 2016 – 2026 (USD Million)
- 9.6.3 The Middle-East and Africa Thyroid Gland Disorder Treatment Market Revenue, By Disease Type, 2016 – 2026
- 9.6.4 The Middle-East and Africa Thyroid Gland Disorder Treatment Market Revenue, By Drug Type, 2016 – 2026
- 9.6.5 GCC Countries
- 9.6.6 Rest of Middle-East Africa
- 9.1 Global Thyroid Gland Disorder Treatment Market: Regional Overview
- Chapter 10 Company Profiles
- 10.1 Pfizer Inc.
- 10.1.1 Company Overview
- 10.1.2 Financial Overview
- 10.1.3 Product Portfolio
- 10.1.4 Business Strategy
- 10.1.5 Recent Developments
- 10.2 AbbVie
- 10.3 Allergan Plc.
- 10.4 Merck & Co., Inc.
- 10.5 GlaxoSmithKline Plc.
- 10.6 Mylan N.V.
- 10.7 RLC Labs, Inc.
- 10.8 Novartis AG
- 10.9 Abbott Laboratories
- 10.10 Sanofi S.A.
- 10.1 Pfizer Inc.
Table Of Figures
List of Figures
FIG. 1 Research Methodology
FIG. 2 Research Methodology – Basic Overview
FIG. 3 Research Methodology – Detailed View
FIG. 4 Global Thyroid Gland Disorder Treatment Market Revenue, 2016 - 2026 (USD Million)
FIG. 5 Porter’s Five Forces Analysis for Global Thyroid Gland Disorder Treatment Market
FIG. 6 Global Thyroid Gland Disorder Treatment Market Attractiveness, By Disease Type
FIG. 7 Global Thyroid Gland Disorder Treatment Market Attractiveness, By Drug Type
FIG. 8 Global Thyroid Gland Disorder Treatment Market Attractiveness, By End-User
FIG. 9 Company Share Analysis, 2019
FIG. 10 Global Thyroid Gland Disorder Treatment Market Revenue Share, By Disease Type, 2019 & 2026
FIG. 11 Global Thyroid Gland Disorder Treatment Market for Hypothyroidism, Revenue (USD Million) 2016 - 2026
FIG. 12 Global Thyroid Gland Disorder Treatment Market for Hyperthyroidism, Revenue (USD Million) 2016 - 2026
FIG. 13 Global Thyroid Gland Disorder Treatment Market Revenue Share, By Drug Type, 2019 & 2026
FIG. 14 Global Thyroid Gland Disorder Treatment Market for Liothyronine, Revenue (USD Million) 2016 - 2026
FIG. 15 Global Thyroid Gland Disorder Treatment Market for Levothyroxine, Revenue (USD Million) 2016 - 2026
FIG. 16 Global Thyroid Gland Disorder Treatment Market for Imidazole, Revenue (USD Million) 2016 - 2026
FIG. 17 Global Thyroid Gland Disorder Treatment Market for Propacil, Revenue (USD Million) 2016 - 2026
FIG. 18 Global Thyroid Gland Disorder Treatment Market for Others, Revenue (USD Million) 2016 - 2026
FIG. 19 Global Thyroid Gland Disorder Treatment Market Revenue Share, by Region, 2019 & 2026
FIG. 20 North America Thyroid Gland Disorder Treatment Market Revenue, 2016 - 2026 (USD Million)
FIG. 21 Europe Thyroid Gland Disorder Treatment Market Revenue, 2016 - 2026 (USD Million)
FIG. 22 Asia Pacific Thyroid Gland Disorder Treatment Market Revenue, 2016 - 2026 (USD Million)
FIG. 23 Latin America Thyroid Gland Disorder Treatment Market Revenue, 2016 - 2026 (USD Million)
FIG. 24 The Middle-East and Africa Thyroid Gland Disorder Treatment Market Revenue, 2016 - 2026 (USD Million)
FIG. 25 Pfizer Inc. Business Segment Revenue Share, 2018 (%)
FIG. 26 Pfizer Inc. Geographical Segment Revenue Share, 2018 (%)
Table Of Tables
List of Tables
TABLE 1 Global Thyroid Gland Disorder Treatment Market: Snapshot
TABLE 2 Drivers of the Thyroid Gland Disorder Treatment Market: Impact Analysis
TABLE 3 Restraints for the Thyroid Gland Disorder Treatment Market: Impact Analysis
TABLE 4 Global Thyroid Gland Disorder Treatment Market Revenue, by Region, 2016 – 2026 (USD Million)
TABLE 5 North America Thyroid Gland Disorder Treatment Market Revenue, by Country, 2016 – 2026 (USD Million)
TABLE 6 North America Thyroid Gland Disorder Treatment Market Revenue, By Disease Type, 2016 – 2026 (USD Million)
TABLE 7 North America Thyroid Gland Disorder Treatment Market Revenue, By Drug Type, 2016 – 2026 (USD Million)
TABLE 8 Europe Thyroid Gland Disorder Treatment Market Revenue, by Country, 2016 – 2026 (USD Million)
TABLE 9 Europe Thyroid Gland Disorder Treatment Market Revenue, By Disease Type, 2016 – 2026 (USD Million)
TABLE 10 Europe Thyroid Gland Disorder Treatment Market Revenue, By Drug Type, 2016 – 2026 (USD Million)
TABLE 11 Asia Pacific Thyroid Gland Disorder Treatment Market Revenue, by Country, 2016 – 2026 (USD Million)
TABLE 12 Asia Pacific Thyroid Gland Disorder Treatment Market Revenue, By Disease Type, 2016 – 2026 (USD Million)
TABLE 13 Asia Pacific Thyroid Gland Disorder Treatment Market Revenue, By Drug Type, 2016 – 2026 (USD Million)
TABLE 14 Latin America Thyroid Gland Disorder Treatment Market Revenue, by Country, 2016 – 2026 (USD Million)
TABLE 15 Latin America Thyroid Gland Disorder Treatment Market Revenue, By Disease Type, 2016 – 2026 (USD Million)
TABLE 16 Latin America Thyroid Gland Disorder Treatment Market Revenue, By Drug Type, 2016 – 2026 (USD Million)
TABLE 17 The Middle-East and Africa Thyroid Gland Disorder Treatment Market Revenue, by Country, 2016 – 2026 (USD Million)
TABLE 18 The Middle-East and Africa Thyroid Gland Disorder Treatment Market Revenue, By Disease Type, 2016 – 2026 (USD Million)
TABLE 19 The Middle-East and Africa Thyroid Gland Disorder Treatment Market Revenue, By Drug Type, 2016 – 2026 (USD Million)
Methodology
FrequentlyAsked Questions
The primary indication for thyroid gland disorder treatments is the presence of thyroid issues, particularly in the thyroid gland. An abnormal discharge of thyroid hormones is the primary definition of thyroid disorder, which is expected to have a significant impact on the regulation of metabolism. Iodine deficiency is the primary cause of thyroid dysfunction.
It is anticipated that the global thyroid gland disorder treatment market will see a consistent rise in the number of patients in both developed and emerging economies. The occurrence of autoimmune syndromes, such as Hashimoto's thyroiditis and Grave's disease, is significantly increased by factors such as a sedentary lifestyle and the increasing pool of geriatrics, which in turn contribute to the increased patient population of thyroid gland syndromes.
The global thyroid gland disorder treatment market size was worth around USD 2.42 billion in 2023 and is predicted to grow to around USD 3.17 billion by 2032.
The global thyroid gland disorder treatment market compound annual growth rate (CAGR) of roughly 3.18% between 2024 and 2032.
North America is anticipated to dominate the thyroid gland disorder treatment market owing to the existence of the efficient healthcare facilities, greater knowledge levels among individuals, and the abundant availability of treatment alternatives. Strategic partnerships among government organizations and pharmaceutical companies are growing in the region, mainly to generate generic drugs and spread knowledge among healthcare experts. Thus the market in North America is likely to become more lucrative.
Some of the most important market players in the global thyroid gland disorder treatment market are Pfizer Inc., AbbVie, Allergan Plc., Merck & Co., Inc., GlaxoSmithKline Plc., Mylan N.V., RLC Labs, Inc., Novartis AG, Abbott Laboratories, and Sanofi S.A., among others.
RelatedNews
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed